The University of Chicago Header Logo

Connection

J. Thistlethwaite to Transplantation, Homologous

This is a "connection" page, showing publications J. Thistlethwaite has written about Transplantation, Homologous.
  1. Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice. Transplantation. 1997 Oct 15; 64(7):959-65.
    View in: PubMed
    Score: 0.130
  2. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts. J Immunol. 1994 Sep 15; 153(6):2738-49.
    View in: PubMed
    Score: 0.105
  3. Does depletion of donor dendritic cells in an organ allograft lead to prolongation of graft survival on transplantation? Transplant Proc. 1989 Feb; 21(1 Pt 1):482-3.
    View in: PubMed
    Score: 0.071
  4. Procurement of both liver and whole pancreas/duodenum allografts from a single donor without the use of interposition vascular grafts on transplantation. Transplant Proc. 1988 Oct; 20(5):833-4.
    View in: PubMed
    Score: 0.069
  5. Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation. 2005 Jan 27; 79(2):228-35.
    View in: PubMed
    Score: 0.054
  6. Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group. Transplantation. 2000 Sep 15; 70(5):784-90.
    View in: PubMed
    Score: 0.040
  7. Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival. Transplantation. 2000 Mar 15; 69(5):904-9.
    View in: PubMed
    Score: 0.038
  8. Differential effect of an anti-CD8 monoclonal antibody on rejection of murine intestine and cardiac allografts. Transplant Proc. 1999 Feb-Mar; 31(1-2):1239-41.
    View in: PubMed
    Score: 0.035
  9. Role of CD8+ and CD4+ T cells in the rejection of murine intestinal allografts. Transplant Proc. 1998 Sep; 30(6):2592-3.
    View in: PubMed
    Score: 0.034
  10. Inhibition of intestinal allograft rejection by an anti-CD8 monoclonal antibody is not mediated by depletion alone. Transplant Proc. 1998 Jun; 30(4):1069-70.
    View in: PubMed
    Score: 0.034
  11. Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation. Transplant Proc. 1998 Mar; 30(2):507-8.
    View in: PubMed
    Score: 0.033
  12. Retransplantation for failed hepatic allografts in children. Transplant Proc. 1997 Feb-Mar; 29(1-2):442-3.
    View in: PubMed
    Score: 0.031
  13. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Clin Transplant. 1996 Aug; 10(4):323-32.
    View in: PubMed
    Score: 0.030
  14. OKT3 escalating dose regimens provide effective therapy for renal allograft rejection. Clin Transplant. 1996 Aug; 10(4):389-95.
    View in: PubMed
    Score: 0.030
  15. Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction. Transplant Proc. 1989 Feb; 21(1 Pt 2):1890-2.
    View in: PubMed
    Score: 0.018
  16. Pancreas-graft immunogenicity and pretreatment with anti-class II monoclonal antibodies. Diabetes. 1989 Jan; 38 Suppl 1:104-8.
    View in: PubMed
    Score: 0.018
  17. Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection. Am J Kidney Dis. 1988 Feb; 11(2):94-8.
    View in: PubMed
    Score: 0.017
  18. T cell immunofluorescence flow cytometry cross-match results in cadaver donor renal transplantation. Transplant Proc. 1987 Feb; 19(1 Pt 1):722-4.
    View in: PubMed
    Score: 0.015
  19. OKT3 treatment of steroid-resistant renal allograft rejection. Transplantation. 1987 Feb; 43(2):176-84.
    View in: PubMed
    Score: 0.015
  20. Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation. 2002 Apr 15; 73(7):1166-9.
    View in: PubMed
    Score: 0.011
  21. Cutting edge: membrane lymphotoxin regulates CD8(+) T cell-mediated intestinal allograft rejection. J Immunol. 2001 Nov 01; 167(9):4796-800.
    View in: PubMed
    Score: 0.011
  22. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway. Transplantation. 2001 May 15; 71(9):1351-4.
    View in: PubMed
    Score: 0.010
  23. Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice. Am J Transplant. 2001 May; 1(1):38-46.
    View in: PubMed
    Score: 0.010
  24. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol. 2001 Feb; 32(2):205-15.
    View in: PubMed
    Score: 0.010
  25. Combined liver and kidney transplantation in children. Transplantation. 2000 Jul 15; 70(1):100-5.
    View in: PubMed
    Score: 0.010
  26. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice. Transplantation. 1999 Jan 15; 67(1):131-7.
    View in: PubMed
    Score: 0.009
  27. Modified surgical model of paratopic small bowel transplantation in mice. J Surg Res. 1998 Dec; 80(2):188-93.
    View in: PubMed
    Score: 0.009
  28. Analysis of fracture prevalence in kidney-pancreas allograft recipients. J Am Soc Nephrol. 1998 Apr; 9(4):677-83.
    View in: PubMed
    Score: 0.008
  29. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. J Immunol. 1997 Dec 01; 159(11):5187-91.
    View in: PubMed
    Score: 0.008
  30. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. Transplant Proc. 1997 Feb-Mar; 29(1-2):307.
    View in: PubMed
    Score: 0.008
  31. Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group. Transplant Proc. 1996 Dec; 28(6):3163-4.
    View in: PubMed
    Score: 0.008
  32. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506. Transplant Proc. 1996 Apr; 28(2):998-9.
    View in: PubMed
    Score: 0.007
  33. Allograft rejection in pediatric recipients of living related liver transplants. Hepatology. 1996 Jan; 23(1):40-3.
    View in: PubMed
    Score: 0.007
  34. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation. 1995 Nov 27; 60(10):1171-8.
    View in: PubMed
    Score: 0.007
  35. Use of cryopreserved vein allogeneic homografts in liver transplantation. Transplant Proc. 1993 Feb; 25(1 Pt 2):1091-2.
    View in: PubMed
    Score: 0.006
  36. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function. Transplant Proc. 1989 Feb; 21(1 Pt 2):1641-2.
    View in: PubMed
    Score: 0.004
  37. Liver transplantation, including the concept of reduced-size liver transplants in children. Ann Surg. 1988 Oct; 208(4):410-20.
    View in: PubMed
    Score: 0.004
  38. Reexposure to OKT3 in renal allograft recipients. Transplantation. 1988 Feb; 45(2):349-53.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.